Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
[WEBINAR] Molecular bioanalysis considerations along the drug development journey 11 days 20 hours 29 mins 43 secs REGISTER NOW!

What are ion mobility MS and collision cross section data?

10 Oct 2017
MS (LC–MS/MS, HRMS, IMS)

Learn about the fundamentals of ion mobility mass spectrometry (IMS) and the benefits of collisional-cross section (CCS) data.


To learn more about Waters and their products please click here.

Top content

  • Waters launches the Xevo TQ Absolute XR at ASMS 2025
  • How can diagnostic laboratories accelerate the clinical adoption of allogeneic cell therapies?
  • Why NGS ELN deployments fail

Related tags

ion ion mobility spectrometry MS
Previous article Next article

Related articles

31 OCT 2010 CLINICAL

Are meaningful predictions of toxicological outcomes in clinical trials based on in vitro diagnostics of preclinical drug candidates possible?

8 JUL 2015 COLLABORATIONS AND MERGERS

Press release: Thermo Fisher Scientific proteomics facility for disease target discovery opens at Gladstone Institutes

18 APR 2012 COLLABORATIONS AND MERGERS

Conference Report: Advances in Metabolic Profiling

31 MAR 2016 IMAGING

A Matrix Toolbox for MALDI Imaging Mass Spectrometry

8 JUN 2011 CHROMATOGRAPHY

Conference Report: Pittcon Conference and Expo 2011

12 JAN 2015 MS (LC–MS/MS, HRMS, IMS)

New MS method of estrogen detection developed

  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
Contact
Contact Us
Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone